Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64

Human Gene Therapy

Volumn 14, Issue 1, 2003, Pages 67-77

  Kumar, Mukesh ^a   Bradow, Brian P ^a   Zimmerberg, Joshua ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; LENTIVIRUS VECTOR; VIRUS PROTEIN;

ARTICLE; BACULOVIRUS; CELL KILLING; CELL LINE; CONTROLLED STUDY; GENE INSERTION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; TARGET CELL; VESICULAR STOMATITIS VIRUS; VIROGENESIS; VIRUS ENVELOPE; VIRUS TITRATION;

ANIMALS; CELL LINE; DNA, RECOMBINANT; GENETIC VECTORS; HIV-1; HUMANS; INDUSTRIAL MICROBIOLOGY; LENTIVIRUS; MEMBRANE GLYCOPROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS;

DNA VIRUSES; INSERTION SEQUENCES; LENTIVIRUS; UNIDENTIFIED BACULOVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0037248595     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340360464723     Document Type: Article

References (47)

1. AIKEN, C. (1997). Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71, 5871-5877.
2. BARSOUM, J., BROWN, R., MCKEE, M., and BOYCE, F.M. (1997). Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum. Gene Ther. 8, 2011-2018.
3. BLISSARD, G.W., and WENZ, J.R. (1992). Baculovirus GP64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion. J. Virol. 66, 6829-6835.
4. BOYCE, F.M., and BUCHER, N.L. (1996). Baculovims-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 93, 2348-2352.
5. BUCHSCHACHER, G.L., and WONG-STAAL, F. (2000). Development of lentiviral vectors for gene therapy for human diseases. Blood 95, 2499-2504.
6. BURNS, J.C., FRIEDMANN, T., DRIEVER, W., BURRASCANO, M., and YEE, J.K. (1993). Vesicular stomatitis virus G protein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90, 8033-8037.
7. BUTLER, S.L., HANSEN, M.S.T., and BUSHMAN, F.D. (2001). A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7, 631-634.
8. CASHION, L.M., BARE, L.A., HARVEY, S., TRINH, Q., ZHU, Y., and DEVLIN, J.J. (1999). Use of enhanced green fluorescent protein to optimize and quantitate infection of target cells with recombinant retroviruses. Biotechniques 26, 924-929.
9. CHERNOMORDIK, L.V., LEIKINA, E., CHO, M.S., and ZIMMERBERG, J. (1995). Control of baculovirus GP64-induced syncytium formation by membrane lipid composition. J. Virol. 69, 3049-3058.
10. CUI, Y., GOLOB, J., KELLEHER, E., YE, Z., PARDOLL, D., and CHENG, L. (2002). Targeting transgene expression to antigen-presenting cells derived from lentivirus-induced engrafting human-hematopoietic stem/progenitor cells. Blood 99, 399-408.
11. DEPOLO, N.J., REED, J.D., SHERIDAN, P.L., TOWNSEND, K., SAUTER, S.L., JOLLY, D.J., and DUBENSKY, T.W., Jr. (2000). VSVG pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol. Ther. 2, 218-222.
12. DUNBAR, C. (2002). Lentiviruses get specific. Blood 99, 397.
13. DULL, T., ZUFFEREY, R., KELLY, M., MANDEL, R.J., NGUYEN, M., TRONO, D., and NALDINI, L. (1998). A third generation lentiviral vector with a conditional packaging system. J. Virol. 72, 8463-8471.
14. HOFMANN, C., and STRAUSS, M. (1998). Baculovirus-mediated gene transfer in the presence of human serum of blood facilitated by inhibition of the complement system. Gene Ther. 5, 531-536.
15. HOFMANN, C., SANDIG, V., JENNINGS, G., RUDOLPH, M., SCHLAG, P., and STRAUSS, M. (1995). Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. U.S.A. 92, 10099-10103.
16. HUSER, A., RUDOLPH, M., and HOFMANN, C. (2001). Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nat. Biotechnol. 19, 451-455.
17. JARVIS, D.L., and FINN, E.E. (1995). Biochemical analysis of the Nglycosylation pathway in baculovirus-infected lepidopteran insect cells. Virology 212, 500-511.
18. KAFRI, T., BLOMER, U., PETERSON, D.A., GAGE, F.H., and VERMA, I.M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314-317.
19. KAFRI, T., VAN PRAAG, H., OUYANG, L., GAGE, F.H., and VERMA, I.M. (1999). A packaging cell line for lentivirus vectors. J. Virol. 73, 576-584.
20. KINGSLEY, D.H., BEHBAHANI, A., RASHTIAN, A., BLISSARD, G.W., and ZIMMERBERG, J. (1999). A discrete stage of baculovirus GP64-mediated membrane fusion. Mol. Biol. Cell 10, 4191-4200.
21. KLAGES, N., ZUFFEREY, R., and TRONO, D. (2000). A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol. Ther. 2, 170-176.
22. KOBINGER, G.P., WEINER, D.J., YU, Q.C., and WILSON, J.M. (2001). Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19, 225-230.
23. KUMAR, M., KELLER, B., MAKALOU, N., and SUTTON, R.E. (2001). Systematic determination of the packaging limit of lentiviral vectors. Hum. Gene Ther. 12, 1893-1905.
24. LANDAU, N.R., PAGE, K.A., and LITTMAN, D.R. (1991). Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65, 162-169.
25. LEIKINA, E., ONARAN, H.O., and ZIMMERBERG, J. (1992). Acidic pH induces fusion of cells infected with baculovirus to form syncytia. FEBS Lett. 304, 221-224.
26. MARCHAL, I., JARVIS, D.L., CACAN, R., and VERBERT, A. (2001). Glycoproteins of insect cells: Sialylated or not? Biol. Chem. 382, 151-159.
27. MIYOSHI, H., TAKAHASHI, M., GAGE, F.H., and VERMA, I.M. (1997). Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 94, 10319-10323.
28. MIYOSHI, H., SMITH, K.A., MOSIER, D.E., VERMA, I.M., and TORBETI', B.E. (1999). Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682-686.
29. NALDINI, L., BLOMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996a). Efficient transfer, integration and sustained long-term expression of the transgene in adult rat brains injected with lentiviral vectors. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388.
30. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996b). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
31. ORY, D.S., NEUGEBOREN, B.A., and MULLIGAN, R.C. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U.S.A. 93, 11400-11406.
32. PAWLIUK, R., WESTERMAN, K.A., FABRY, M.E., and PAYEN, E. (2001). Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 294, 2368-2371.
33. PLONSKY, I., and ZIMMERBERG, J. (1996). Initial fusion pore induced by baculovirus GP64 is large and forms quickly. J. Cell Biol. 135, 1831-1839.
34. PLONSKY, I., CHO, M.S., OOMENS, A.G., BLISSARD, G., and ZIMMERBERG, J. (1999). An analysis of the role of target membrane on the GP-64-induced fusion pore. Virology 253, 65-76.
35. REISER, J. (2000). Production and concentration of pseudotyped HIV1-based gene transfer vectors. Gene Ther. 7, 910-913.
36. REISER, J., LAI, Z., ZHANG, X.Y., and BRADY, R.O. (2000). Development of multigene and regulated lentiviral vectors. J. Virol. 74, 10589-10599.
37. SASTRY, L., JOHNSON, T., HOBSON, M.J., SMUCKER, B., and CORNETTA, K. (2002). Titering lentiviral vectors: Comparison of DNA, RNA and marker expression methods. Gene Ther. 9, 1155-1162.
38. SCHWARTZ, A.L., FRIDOVICH, S.E., and LODISH, H.F. (1982). Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. J. Biol. Chem. 257, 4230-4237.
39. STITZ, J., BUCHHOLZ, C.J., ENGELSTADTER, M., UCKERT, W., BLOEMER, U., SCHMITT, I., and CICHUTEK, K. (2000). Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273, 16-20.
40. SUTTON, R.E., and LITTMAN, D.R. (1996). Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70, 7322-7326.
41. SUTTON, R.E., WU, H.T., RIGG, R., BOHNLEIN, E., and BROWN, P.O. (1998). Human immunodeficiency virus type I vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72, 5781-5788.
42. TEYSSET, L., BURNS, J.C., SHIKE, H., SULLIVAN, B.L., BUCHETON, A., and TERZIAN, C. (1998). A Moloney murine leukemia virus-based retroviral vector pseudotyped by the insect retroviral gypsy envelope can infect Drosophila cells. J. Virol. 72, 853-856.
43. TRONO, D. (2000). Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Ther. 7, 20-23.
44. YANG, Y., VANIN, E.F., WHITT, M.A., and FORNEROD, M. (1995). Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum. Gene Ther. 6, 1203-1213.
45. YOSHIDA, Y., EMI, N., and HAMADA, H. (1997). VSVG-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochem. Biophys. Res. Commun. 232, 379-382.
46. ZENNOU, V., SERGUERA, C., SARKIS, C., COLIN, P., PERRET, E., MALLET, J., and CHARNEAU, P. (2001). The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19, 446-450.
47. ZUFFEREY, R., DULL, T., MANDEL, R.J., BUKOVSKY, A., QUIROZ, D., NALDINI, L., and TRONO, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.